Innogenetics grants GlaxoSmithKline Biologicals a license for use of HPV SPF10 genotyping technology in clinic Cervical cancer is caused by persistent infection with HPV, and is the second most common cancer among women worldwide, with some 500,000 new cases and 250,000 deaths due to this disease each year.In Europe, there are approximately 50,000...
UCB's Cimzia filed with EMEA for treatment of rheumatoid arthritis 'Along with a fast onset of action, Cimzia has been shown to rapidly reduce the rate of progression of joint damage and to improve measurements of patients' physical function,' said Olav Hellebo, President of Inflammation Operations for UCB....
Quagga mussels threaten western U.S. water and electric plants, Cornell expert tells legislators The threat was outlined by Chuck O'Neill, a senior extension associate with Cornell and New York Sea Grant, in testimony before the U.S.House of Representatives Committee on Natural Resources Subcommittee on Water and Power, June 24.
He...
DxS launches cancer mutation kit for K-RAS in Australia DxS' TheraScreen K-RAS kit allows clinicians to screen patients for mutations in the K-RAS gene, which correlates with poor prognosis if patients are treated with a class of drugs called EGFR inhibitors.The gene is mutated in...
Direvo and Danisco/Genencor sign second cooperation agreement Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the product or products developed under this collaboration.Direvo and Danisco/Genencor sign second cooperation agreement.
mtm laboratories appoints Bob Silverman as CEO - mtm laboratories, a privately held biotech company globally developing, manufacturing and commercializing in vitro diagnostics for cervical cancer screening, today announced that it has appointed Bob Silverman as its new CEO.Mr...
Western European in vitro diagnostics market sustained by new technologies - Despite issues such as rising R&D costs, poor reimbursement and a decline in prices, the emergence of new technologies is boosting the Western European in vitro diagnostics (IVD) markets.While the introduction of automation and...
Oxfordshire Bioscience Network branches out from Brookes sets sights on accelerating growth; GBP1M cost saving xfordshire Bioscience Network (OBN) announces its expansion, spinning-out from Oxford Brookes University, the network is building even stronger links between companies in the industry.OBN is the leading biotech network in the South East,...
Fluxion Biosciences announces distributor for Switzerland G to distribute BioFlux line of live cell imaging products01 Jul 2008 - Fluxion Biosciences announced an exclusive distribution agreement with Basel-based Bucher Biotec AG.Bucher will handle sales and service in Switzerland of Fluxion's...
Stable dust for preventing hay fever and allergic asthma - March 2007 saw the founding of a new company, Protectimmun GmbH, to exploit groundbreaking research in allergy prevention from the Research Center Borstel (FZB) and the Ruhr-Universitt Bochum.The goal of the company is to develop a drug...
